B-Cell Lymphomas Global Clinical Trials Review, H1, 2012
B-Cell Lymphomas Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, H1, 2012" provides data on the B-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on B-Cell Lymphomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating B-Cell Lymphomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Summary
GlobalData's clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, H1, 2012" provides data on the B-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on B-Cell Lymphomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating B-Cell Lymphomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Contents
IntroductionB-Cell Lymphomas
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of B-Cell Lymphomas
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in B-Cell Lymphomas Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Millennium Pharmaceuticals, Inc.
Clinical Trial Overview of Millennium Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Takeda Pharmaceutical Company Limited
Novartis AG
Clinical Trial Overview of Novartis AG
Sanofi
Clinical Trial Overview of Sanofi
Pharmacyclics, Inc.
Clinical Trial Overview of Pharmacyclics, Inc.
SymBio Pharmaceuticals Limited
Clinical Trial Overview of SymBio Pharmaceuticals Limited
Biogen Idec Inc.
Clinical Trial Overview of Biogen Idec Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Cephalon, Inc.
Clinical Trial Overview of Cephalon, Inc.
Cell Therapeutics, Inc.
Clinical Trial Overview of Cell Therapeutics, Inc.
Seattle Genetics, Inc.
Clinical Trial Overview of Seattle Genetics, Inc.
MedImmune, LLC
Clinical Trial Overview of MedImmune, LLC
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
IMMUNOMEDICS, INC
Clinical Trial Overview of IMMUNOMEDICS, INC
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Groupe d'Etudes de Lymphomes de L'Adulte
Clinical Trial Overview of Groupe d'Etudes de Lymphomes de L'Adulte
Southwest Oncology Group
Clinical Trial Overview of Southwest Oncology Group
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Duke University
Clinical Trial Overview of Duke University
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
Weill Cornell Medical College
Clinical Trial Overview of Weill Cornell Medical College
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Groupe d Etude des Lymphomes de l Adulte
Clinical Trial Overview of Groupe d Etude des Lymphomes de l Adulte
UCLA's Jonsson Comprehensive Cancer Center
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center
Sarah Cannon Research Institute
Clinical Trial Overview of Sarah Cannon Research Institute
Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS
Clinical Trial Overview of Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS
Swiss Group for Clinical Cancer Research
Clinical Trial Overview of Swiss Group for Clinical Cancer Research
University of Wisconsin Madison
Clinical Trial Overview of University of Wisconsin Madison
Stanford University
Clinical Trial Overview of Stanford University
H. Lee Moffitt Cancer Center & Research Institute
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Zone, 2012*
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, BRIC Countries, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, G7 Countries, 2012*
B-Cell Lymphomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, E7 Countries, 2012*
B-Cell Lymphomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Phase, 2012*
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
B-Cell Lymphomas Therapeutics Market, Global, Suspended Clinical Trials, 2012*
B-Cell Lymphomas Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
B-Cell Lymphomas Therapeutics Market, Global, Terminated Clinical Trials, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Millennium Pharmaceuticals, Inc., 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by SymBio Pharmaceuticals Limited, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Therapeutics, Inc., 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by IMMUNOMEDICS, INC, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d'Etudes de Lymphomes de L'Adulte, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d Etude des Lymphomes de l Adulte, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Swiss Group for Clinical Cancer Research, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012*
LIST OF FIGURES
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, BRIC Countries (%), 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, G7 Countries (%), 2012*
B-Cell Lymphomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, E7 Countries (%), 2012*
B-Cell Lymphomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology Skip to top